Please use this identifier to cite or link to this item: https://doi.org/10.1053/j.gastro.2011.11.021
Title: T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease
Authors: Bodd, M.
Kim, C. 
Lundin, K.E.A.
Sollid, L.M.
Keywords: DQ2.2-glut-L-1
Genetics
Immune Response
Inflammatory Reaction
Issue Date: Mar-2012
Citation: Bodd, M., Kim, C., Lundin, K.E.A., Sollid, L.M. (2012-03). T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease. Gastroenterology 142 (3) : 552-561. ScholarBank@NUS Repository. https://doi.org/10.1053/j.gastro.2011.11.021
Abstract: Background & Aims: Celiac disease is a diet-induced, T cellmediated enteropathy. The HLA variant DQ2.5 increases risk of the disease, and the homologous DQ2.2 confers a lower level of risk. As many as 5% of patients with celiac disease carry DQ2.2 without any other risk alleles. Epitopes commonly recognized by T cells of patients with HLA-DQ2.5 bind stably to DQ2.5 but unstably to DQ2.2. We investigated the response to gluten in patients with HLA-DQ2.2. Methods: We generated intestinal T-cell lines and clones from 7 patients with HLA-DQ2.2 (but not DQ2.5) and characterized the responses of the cells to gluten. The epitope off-rate was evaluated by gel filtration and T cellbased assays. Peptide binding to DQ2.2 was studied with peptide substitutes and DQ2 mutants. Results: Patients with DQ2.2 and no other risk alleles had gluten-reactive T cells that did not respond to the common DQ2.5-restricted T-cell epitopes. Instead, many of the T cells responded to a distinct epitope that was not recognized by those from patients with HLA-DQ2.5. This immunodominant epitope bound stably to DQ2.2. A serine residue at P3 was required for the stable binding. The effect of this residue related to a polymorphism at DQα22 that was previously shown to determine stable binding of peptides to DQ2.5. Conclusions: High levels of kinetic stability of peptidemajor histocompatibility complexes are required to generate T-cell responses to gluten in celiac disease; the lower risk from DQ2.2 relates to constraints imposed on gluten peptides to stably bind this HLA molecule. These observations increase our understanding of the role of the major histocompatibility complex in determining T-cell responses in patients with celiac disease and are important for peptide-based vaccination strategies. © 2012 AGA Institute.
Source Title: Gastroenterology
URI: http://scholarbank.nus.edu.sg/handle/10635/101833
ISSN: 00165085
DOI: 10.1053/j.gastro.2011.11.021
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

44
checked on Sep 16, 2019

WEB OF SCIENCETM
Citations

40
checked on Sep 9, 2019

Page view(s)

65
checked on Sep 7, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.